Lataa...
Anthracycline-induced cardiotoxicity: A case report and review of literature
BACKGROUND: Doxorubicin and other anthracycline derivatives inhibit topoisomerase II and is an important class of cytotoxic chemotherapy in cancer treatment. The use of anthracycline is limited by dose-dependent cardiotoxicity, which may manifest initially as asymptomatic cardiac dysfunction with su...
Tallennettuna:
| Julkaisussa: | World J Cardiol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7821007/ https://ncbi.nlm.nih.gov/pubmed/33552401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4330/wjc.v13.i1.28 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|